BMY Is Down 9% After 1,339 Days. What History Says Now

BMY Exits Yellow Zone After 1,339 Days Down. What History Says

Bristol-Myers Squibb Company (BMY) is now down 9% from its all-time high as of August 17, 2026, having just exited the yellow zone after 1,339 days. The Drawdown Severity Score™ has improved to 1.8, placing the stock in the green zone. In 52 comparable prior drops of 5% or more, the stock experienced an average drawdown duration of 232 days.

Where It Was: Peak Severity, Drawdown Depth, and Duration

The asset has spent 1,339 days in this drawdown, a duration that far exceeds its historical averages. During this period, the severity score reached levels that placed the stock in the yellow zone, which represents a heightened risk profile. This prolonged correction began after the stock reached its all-time high of $71.04.

Our data shows that long-duration drawdowns behave differently than sharp, short-lived sell-offs. When an asset remains below its historical peak for over 1,300 days, the recovery trajectory tends to be gradual. The transition out of the yellow zone indicates that the downside momentum has stabilized.

An average drawdown duration of 64 days across all 205 historical events indicates that BMY typically resolves its price corrections within approximately two months. The current duration of 1,339 days represents a massive statistical departure from this norm, spanning over three and a half years. This extreme duration is what kept the asset locked in the yellow zone, as our model penalizes persistent time spent below historical highs even when the absolute depth of the drawdown remains relatively shallow at -9.0%.

Current Position and Severity Context

As of August 17, 2026, BMY is trading at $64.63. This price represents a remaining drawdown of -9.0% from its all-time high of $71.04. The Drawdown Severity Score™ has improved to 1.8, placing the stock in the green zone.

A Drawdown Severity Score™ of 1.8 indicates a "Slightly Elevated" risk state. This classification means that while the stock is still trading below its peak, the immediate risk of further decline has moderated relative to its historical behavior. The transition from the yellow zone to the green zone suggests that the asset is entering a more stable phase.

The green zone represents a state where the asset's risk metrics are returning to baseline levels. In our model, a score below 2.0 generally places an asset in this green, or "Slightly Elevated", risk category. The improvement of the Drawdown Severity Score™ to 1.8 indicates that the rate of change in the price has stabilized. This stabilization is a necessary precursor for any sustained recovery, as it suggests that the selling pressure that characterized the yellow zone phase has dissipated.

To provide historical valuation context, as of 2026-08-15, the Price-to-Sales ratio (P/S) for BMY is 2.7, which sits in the 35th percentile of its own daily P/S record since 2006-08-14, remaining within its own typical range relative to its historical median of 3.2. Meanwhile, the EV-to-EBITDA ratio (EV/EBITDA) is 9.8, placing it in the 41st percentile of its own daily EV/EBITDA record since 2006-08-14, also within its own typical range compared to its historical median of 11.1.

Historical Comparison: How Prior Comparable Recoveries Evolved

To understand the historical context of this move, we look at the entire dataset for BMY. The stock has experienced a total of 205 historical drawdown events in our database since 2006. The average maximum drawdown across all 205 events is -4.7%, with an average drawdown duration of 64 days.

The current drawdown of -9.0% is deeper and more than twenty times longer than these average metrics. To find a more accurate comparison, we isolate historical events where the stock dropped by 5% or more. Our data shows that BMY has dropped by 5% or more from its peak a total of 52 times.

The average duration of these 52 comparable drops is 232 days. The current duration of 1,339 days is more than five times longer than this historical average. This highlights just how protracted the current correction has been relative to the stock's historical patterns.

When we look at the 52 historical instances where BMY fell by 5% or more, we see a wide distribution of recovery timelines. While the average duration of these comparable drops is 232 days, the current event has lasted 1,339 days, making it one of the longest drawdowns in the stock's modern trading history since 2006. This suggests that the stock has undergone a major repricing phase rather than a typical cyclical pullback.

Analyzing the Severity Transition

The Drawdown Severity Score™ is a proprietary metric that evaluates both the depth and the duration of an asset's decline relative to its historical behavior. During the yellow zone phase, the combination of a persistent -9.0% drawdown and the extreme duration of over 1,300 days kept the severity score elevated. The transition to the green zone suggests that the price has stabilized sufficiently, or the passage of time has integrated this level into the asset's normal volatility profile.

If we analyze the 52 historical instances where the stock experienced a 5% or greater drawdown, we see that the recovery phase often begins with a stabilization of the severity score before the price fully reclaims its previous peak. The transition from yellow to green is a critical statistical marker in this process. It represents a shift from an active, high-risk decline to a period of consolidation or gradual recovery.

The mathematical asymmetry of drawdowns is a crucial concept for risk management. A drop of -9.0% requires a 9.9% increase in price to return to the previous peak of $71.04. This relationship is defined by the formula where the recovery percentage is equal to one divided by the quantity of one plus the drawdown decimal, minus one. As the drawdown depth increases, the required recovery percentage rises exponentially. For BMY, the required 9.9% gain is relatively modest compared to deeper market corrections, but the time taken to stabilize highlights the persistence of the downward trend.

Data Limits and Methodology

Our analysis relies strictly on verified price, drawdown, severity, and duration data. We do not incorporate external factors, corporate earnings, regulatory decisions, or market sentiment into this model. The Drawdown Severity Score™ is a purely mathematical representation of price action relative to BMY's own historical drawdown distribution.

By focusing solely on price and drawdown history, we eliminate the subjective narrative that often clouds market analysis. This data-only approach allows investors to observe how the current price action aligns with historical patterns. It provides a clear, quantitative baseline without the bias of external news or causal speculation.

Our data-only approach is designed to isolate price action from the narrative-driven explanations often found in financial media. While external reports may attribute price movements to specific events, our model focuses entirely on the mathematical footprint of the drawdown. This allows us to evaluate the current state of BMY relative to its own 20-year trading history without relying on qualitative assumptions.

What to Watch: Key Severity Thresholds

To understand where BMY stands going forward, investors can monitor specific price and drawdown thresholds that would alter the current risk profile. If BMY experiences further downward pressure, a drop back below the -10% drawdown mark (which corresponds to a price of $63.94) could trigger a return to the yellow zone. This would indicate a re-acceleration of risk.

Conversely, to achieve a complete recovery and exit the drawdown entirely, the stock must rise from its current price of $64.63 to reclaim its all-time high of $71.04. This represents a required gain of approximately 9.9% from current levels. As the stock remains in the green zone, the Drawdown Severity Score™ will continue to adjust based on daily price movements.

To monitor BMY's progress, investors can watch the severity score for any signs of reversal. A score rising back toward 2.0 or higher would signal that the stock is losing momentum and potentially heading back into the yellow zone. Conversely, if the score continues to decline toward 1.0 or lower, it would indicate that the stock is approaching a complete statistical normalization, even before it fully reclaims the $71.04 peak.